1 min read|27 words
1.7 billion people carry TB infection globally, but 85–95% naturally control it. New immune biomarkers could identify the 5–10% at risk of progression. Medicine
Read the full article on GMJ Newsroom →
Was this article helpful?
Key Finding: Early immune markers could identify which TB-infected people will develop active disease
MD, MPH, PhD. Editor-in-Chief, Georgian Medical Journal (GMJ). Professor and Head, School of Public Health, David Tvildiani Medical University (DTMU), Tbilisi, Georgia. Chair, Public Health Institute of Georgia (PHIG). President, Accréditation Sans Frontières (ASF), Paris. Secretary/Treasurer, UEMS Section of Public Health. WHO Consultant, Health and Migration, Geneva. Former Member, UN Secretary-General's Independent Accountability Panel for Every Woman, Every Child, Every Adolescent (IAP-EWEC, 2016–2021). ORCID: 0000-0001-7609-4515.
